Population of the World is 7,095,217,980 (July 2013 est.), err 7 billion, one in a million affected by HoFH equates to 7,095 persons, yasser’s source for 15,000 (no link) must be guesstimating slightly more than two HoFH cases per million (vs the FDA estimate of one)…USA GDP per capita is $49,800 (2012 est.), World GDP per capita is $12,400 (2012 est.). Based on 2009 IRS statistics roughly one in two hundred of those afflicted in the USA could afford the ANNUAL 300K prescription (if they wanted to afford it). Course the USA is more affluent than most of the rest of the world, for the sake of argument we’ll assume one in five hundred of those afflicted worldwide could if the chose afford it (in reality it’ll be far fewer)…assuming all of those chose juxtapid (verse the far less expensive treatments), you’d have a grand total of 30 customers.
Censored, time to come up to this Millennia. The link was the CNBC video with the CEO of AEGR. You can Google it or pull the link from the Yahoo quote/news page. It was from the Jume 5 interview if I remember correctly. The CEO based the 15,000 number based on reported cases worldwide and confirmed by corroborating numbers from their own patient registry.
YOUR outdated number is from Wiki which, if you take 10-seconds to follow the link for the source data of 1 in a million, is from a 2003 article which references studies back to 1973.
You also STILL cannot conceive of INSURANCE, and how AEGR already has agreements with companies covering 98% of the insured population.
Get with the program.
YOU are e one spreading garbage and misinformation.